艾伯維公司
DE ˙ XTRA ˙ US00287Y1091
€188.50 ↑0.35 (0.19%)
2026-06-04
分享價格
SecurityDE:4AB / AbbVie Inc.
InstitutionFront Row Advisors LLC
Latest Disclosed Ownership25,204 shares
Latest Disclosed Value $ 5,481,626
Front Row Advisors LLC reports 0.26% increase in ownership of 4AB / AbbVie Inc.

On May 19, 2026 - Front Row Advisors LLC filed a 13F-HR form disclosing ownership of 25,204 shares of AbbVie Inc. (DE:4AB) valued at $4,672,822 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 12, 2026 disclosing 25,138 shares of AbbVie Inc.. This represents a change in shares of 0.26% during the quarter. The current value of the position is $4,750,954 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-19 2026-03-31 13F ABBVIE INC COM Stock 00287Y109 25,204 66 0.26 5,482 -4.56 1.8542
2026-02-12 2025-12-31 13F ABBVIE INC COM Stock 00287Y109 25,138 -328 -1.29 5,744 -2.59 1.9149
2025-11-17 2025-09-30 13F ABBVIE INC COM Stock 00287Y109 25,466 -349 -1.35 5,896 23.06 1.9815
2025-08-18 2025-06-30 13F ABBVIE INC COM Stock 00287Y109 25,815 -263 -1.01 4,792 -12.30 1.6669
2025-05-15 2025-03-31 13F ABBVIE INC COM Stock 00287Y109 26,078 -878 -3.26 5,464 14.05 2.0996
2025-02-12 2024-12-31 13F ABBVIE INC COM Stock 00287Y109 26,956 -116 -0.43 4,790 -10.40 1.6546
2024-11-14 2024-09-30 13F ABBVIE INC COM Stock 00287Y109 27,072 -274 -1.00 5,346 13.99 1.9073
2024-08-16 2024-06-30 13F ABBVIE INC COM Stock 00287Y109 27,346 265 0.98 4,690 -4.89 1.6306
2024-05-14 2024-03-31 13F ABBVIE INC COM Stock 00287Y109 27,081 269 1.00 4,931 18.68 1.8283
2024-02-15 2023-12-31 13F ABBVIE INC COM Stock 00287Y109 26,812 -426 -1.56 4,155 2.34 1.9088
2023-11-15 2023-09-30 13F ABBVIE INC COM Stock 00287Y109 27,238 -507 -1.83 4,060 135,233.33 1.8709
2023-08-15 2023-06-30 13F ABBVIE INC COM Stock 00287Y109 27,745 39 0.14 4 -25.00 1.6625
2023-05-23 2023-03-31 13F/A-1 ABBVIE INC COM Stock 00287Y109 27,706 318 1.16 4 0.00 2.1178
2023-05-15 2023-03-31 13F ABBVIE INC COM Stock 00287Y109 4,415 -22,973 3 1.4014
2023-02-15 2022-12-31 13F ABBVIE INC COM Stock 00287Y109 27,388 -1,099 -3.86 4 -99.90 2.2852
2022-11-16 2022-09-30 13F ABBVIE INC COM Stock 00287Y109 28,487 -83 -0.29 3,823 -12.64 1.9790
2022-08-15 2022-06-30 13F ABBVIE INC COM STOCK 00287Y109 28,570 -185 -0.64 4,376 -6.13 2.1530
2022-05-11 2022-03-31 13F ABBVIE INC COM Stock 00287Y109 28,755 40 0.14 4,662 19.91 1.8795
2022-03-09 2021-12-31 13F ABBVIE INC COM Stock 00287Y109 28,715 857 3.08 3,888 29.38 1.4507
2021-11-03 2021-09-30 13F ABBVIE INC COM Stock 00287Y109 27,858 -43 -0.15 3,005 -8.66 1.2682
2021-08-23 2021-06-30 13F ABBVIE INC COM Stock 00287Y109 27,901 385 1.40 3,290 10.48 1.3498
2021-04-28 2021-03-31 13F ABBVIE INC COM STOCK 00287Y109 27,516 1,024 3.87 2,978 4.90 1.4427
2021-02-25 2020-12-31 13F ABBVIE INC COM Stock 00287Y109 26,492 -323 -1.20 2,839 0.92 1.4548
2020-11-30 2020-09-30 13F ABBVIE INC COM Stock 00287Y109 26,815 -668 -2.43 2,813 4.26 1.4884
2020-08-17 2020-06-30 13F ABBVIE INC COM Stock 00287Y109 27,483 -415 -1.49 2,698 17.66 1.6730
2020-05-08 2020-03-31 13F ABBVIE INC COM Stock 00287Y109 27,898 1,725 6.59 2,293 -1.04 1.5494
2020-02-14 2019-12-31 13F ABBVIE INC COM Stock 00287Y109 26,173 -1,261 -4.60 2,317 11.56 1.5110
2019-11-08 2019-09-30 13F ABBVIE INC COM Stock 00287Y109 27,434 -431 -1.55 2,077 2.52 1.4802
2019-08-27 2019-06-30 13F ABBVIE INC COM Stock 00287Y109 27,865 267 0.97 2,026 -8.90 1.4753
2019-05-17 2019-03-31 13F/A-1 ABBVIE INC COM Stock 00287Y109 27,598 590 2.18 2,224 -10.68 1.7318
2019-05-16 2019-03-31 13F ABBVIE INC COM Stock 00287Y109 27,008 0 2,490
2019-02-13 2018-12-31 13F ABBVIE INC COM Stock 00287Y109 27,008 -587 -2.13 2,490 13.65 2.1660
2018-11-13 2018-09-30 13F ABBVIE INC COM Stock 00287Y109 27,595 -245 -0.88 2,191 -15.47 1.5358
2018-07-31 2018-06-30 13F ABBVIE INC COM Stock 00287Y109 27,840 119 0.43 2,592 -1.22 1.6588
2018-05-21 2018-03-31 13F ABBVIE INC COM Stock 00287Y109 27,721 -82 -0.29 2,624 -2.42 1.8383
2018-01-31 2017-12-31 13F ABBVIE INC COM Stock 00287Y109 27,803 27,803 2,689 2.1412
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.